Quantcast
Last updated on April 18, 2014 at 16:58 EDT

Latest Attention-deficit hyperactivity disorder controversies Stories

2013-10-31 12:27:20

Shire has renamed the program in memory of colleague Michael Yasick PHILADELPHIA, October 31, 2013 /PRNewswire/ -- Shire [http://www.shire.com ] is pleased to announce that it has launched the 2014 Michael Yasick ADHD Scholarship by Shire. The scholarship program is for individuals in the United States diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) who are accepted to or will be enrolled in an undergraduate program at an accredited college, university, trade...

2013-10-29 23:29:43

ImpactADHD expands online presence with tools, training and resources to better support, coach and advise families with ADHD children. Atlanta, GA (PRWEB) October 29, 2013 ImpactADHD opened ADHD Awareness Month this October with the launch of their new website, ImpactADHD.com. The small award-winning business offers innovative approaches to parenting children with ADHD. Since its inception less than two years ago, ImpactADHD has seen a dramatic increase in the demand for its resources and...

2013-10-15 21:00:36

Reports new study in Biological Psychiatry Some people grow out of their childhood attention-deficit/hyperactivity disorder (ADHD) and some don't. In fact, around 50% of individuals diagnosed as children continue to suffer from ADHD as adults. Researchers are trying to understand the reasons why, and relatedly, whether there are any differences that distinguish the two groups. Gender, ethnicity, socioeconomic class, and symptom severity have already been ruled out as potentials. So,...

2013-10-03 12:25:48

TORONTO, Oct. 3, 2013 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a specialty pharmaceutical company leveraging its proprietary technologies to optimize the delivery of previously approved drug products, today announced that its wholly owned subsidiary has generated positive interim Phase I/II results from an ongoing study of HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder...

2013-10-01 12:30:16

Poster Presentation at U.S. Psychiatric and Mental Health Congress 2013 Demonstrates Potential to Detect Feigned ADHD with Quotient's Computerized Assessment Technology BLOOMINGTON, Minn., Oct. 1, 2013 /PRNewswire/ -- Pearson, the world's leading learning company, announced today that the company will present a poster on results from a pilot study of the company's newly acquired Quotient(®) ADHD Test demonstrating the technology's ability to detect individuals attempting to fake...

2013-08-15 16:24:11

BOULDER, Colo., Aug. 15, 2013 /PRNewswire/ -- NEBA Health, LLC announces today that Dr. Steven M. Snyder, Research and Development Vice President, has earned US Patent 8,509,884. The patent protects a key aspect of the NEBA system: integrating the biomarker with a clinician's workup for ADHD. "NEBA is not a standalone diagnostic," said Dr. Snyder. "After the clinician's ADHD evaluation, NEBA helps them determine if the symptoms are due to ADHD or if further testing is warranted."...

2013-08-05 23:02:40

A new study by Abt Associates shows wide geographic disparities in the treatment of ADHD which suggests flawed management of the disorder. Cambridge, MA (PRWEB) August 05, 2013 The use of amphetamine medications to treat attention deficit hyperactivity disorder (ADHD) in the United States varies widely from state to state and even more dramatically from one county to another, according to a new study by Abt Associates, showing treatment disparities are greater than previously assessed in...

2013-07-29 16:25:27

Eighty One Percent of Participating Children No Longer have ADHD after Program NEW JERSEY CITY, N.J., July 29, 2013 /PRNewswire/ -- A new randomized control study conducted by doctors in the Medical Neurology and Neuroscience field found that a drug-free, multi-modal program is significantly effective for eliminating symptoms associated with ADHD, as well as producing significant cognitive improvement. After a 12-week intervention program, the researchers found that 81 percent of...

Breastfeeding May Protect Against ADHD
2013-07-23 09:03:56

Rebekah Eliason for redOrbit.com - Your Universe Online Breastfeeding is widely accepted as having a positive impact on development and providing infants protection against disease. Surprisingly, a new study released from Tel Aviv University has linked breastfeeding with a lower risk of attention deficit hyperactivity disorder (ADHD), which is the most commonly diagnosed neurobehavioral disorder in children and teens. Dr. Aviva Mimouni-Bloch, along with a team of researchers, sought to...

2013-07-22 20:21:09

AUGUSTA, Ga., July 22, 2013 /PRNewswire/ -- NEBA Health, LLC releases today key study results regarding the FDA approval of NEBA®, the first brain wave test to help clinicians assess ADHD in children and adolescents. FDA cleared NEBA for marketing on July 15, 2013. About NEBA NEBA integrates an ADHD biomarker together with a clinician's ADHD evaluation. In other words, NEBA is not used as a stand-alone diagnostic. The clinician still conducts their ADHD evaluation as in their...